Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by:...

FDA Recall #D-0156-2026 — Class III — October 10, 2025

Recall #D-0156-2026 Date: October 10, 2025 Classification: Class III Status: Ongoing

Product Description

Fesoterodine Fumarate, Extended-release Tablets, 4 mg, 30-count bottle, Rx only, Manufactured by: Alembic Pharmaceuticals Limited, Panelav 389350, Gujarat, India, Manufactured for: Alembic Pharmaceuticals, Inc., Bedminster, NJ 07921, USA, NDC 62332-175-30

Reason for Recall

Failed Impurities/Degradation Specifications: Due to levels of 'Diester Impurity' exceeding the specification limit.

Recalling Firm

Alembic Pharmaceuticals Limited — Panchmahal

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

4,884 30-count bottles

Distribution

Nationwide in the USA.

Code Information

Lot # 2405006633, Exp Date: 03/31/2026

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated